Mikhail Inyushin on A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study.
COMMENT The AMBAR clinical study is promising but also raises questions. If plasmapheresis (Apheresis) with plasma exchange to young plasma or to patients’ own filtered plasma with albumin exchange can reduce development of the disease, it may well establish a pe